Literature DB >> 15756939

Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Mark A Lovell1, Shuling Xiong, William R Markesbery, Bert C Lynn.   

Abstract

Increasing evidence supports a role for altered mitochondrial function in the pathogenesis of neuron degeneration in Alzheimer's disease (AD). Although several studies have examined the effect of amyloid beta peptide (Abeta), on activities of individual proteins in primary neuron cultures, there have been no studies of the effects of Abeta on the mitochondrial proteome. Here, we quantitatively measured changes in mitochondrial proteins of primary rat cortical neuron cultures exposed to 25 microM Abeta(25-35) for 16 h using isotope coded affinity tag (ICAT) labeling and 2-dimensional liquid chromatography/tandem mass spectrometry (2D-LC/MS/MS) which allows simultaneous identification and quantification of cysteine-containing proteins. The analysis of enriched mitochondrial fractions identified 10 proteins including sodium/potassium-transporting ATPase, cofilin, dihydropyrimidinase, pyruvate kinase and voltage dependent anion channel 1 that were statistically significantly (P < 0.05) altered in Abeta-treated cultures. Elevations of proteins associated with energy production suggest that cells undergoing Abeta-mediated apoptosis increase synthesis of proteins essential for ATP production and efflux in an attempt to maintain metabolic function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756939     DOI: 10.1007/s11064-004-9692-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  55 in total

1.  Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.

Authors:  B C Yoo; M Fountoulakis; N Cairns; G Lubec
Journal:  Electrophoresis       Date:  2001-01       Impact factor: 3.535

2.  The rat liver mitochondrial proteins.

Authors:  Michael Fountoulakis; Peter Berndt; Hanno Langen; Laura Suter
Journal:  Electrophoresis       Date:  2002-01       Impact factor: 3.535

3.  Mitochondrial translocation of cofilin is an early step in apoptosis induction.

Authors:  Boon Tin Chua; Christiane Volbracht; Kuan Onn Tan; Rong Li; Victor C Yu; Peng Li
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

Review 4.  Mitochondria in Alzheimer's disease.

Authors:  Russell H Swerdlow; Stephen J Kish
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

5.  An alternative strategy to determine the mitochondrial proteome using sucrose gradient fractionation and 1D PAGE on highly purified human heart mitochondria.

Authors:  Steven W Taylor; Dale E Warnock; Gary M Glenn; Bing Zhang; Eoin Fahy; Sara P Gaucher; Roderick A Capaldi; Bradford W Gibson; Soumitra S Ghosh
Journal:  J Proteome Res       Date:  2002 Sep-Oct       Impact factor: 4.466

6.  Enhanced G-protein activation by a mixture of Abeta(25-35), Abeta(1-40/42) and zinc.

Authors:  Zs Molnár; P Kovács; I Laczkó; K Soós; L Fülöp; B Penke; I Lengyel
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

7.  Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells.

Authors:  I Kruman; Q Guo; M P Mattson
Journal:  J Neurosci Res       Date:  1998-02-01       Impact factor: 4.164

8.  Acid-labile isotope-coded extractants: a class of reagents for quantitative mass spectrometric analysis of complex protein mixtures.

Authors:  Yongchang Qiu; Eric A Sousa; Rodney M Hewick; Jack H Wang
Journal:  Anal Chem       Date:  2002-10-01       Impact factor: 6.986

9.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

10.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

View more
  11 in total

Review 1.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

2.  Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers.

Authors:  Hansen Wang; Lisa D Muiznieks; Punam Ghosh; Declan Williams; Michael Solarski; Andrew Fang; Alejandro Ruiz-Riquelme; Régis Pomès; Joel C Watts; Avi Chakrabartty; Holger Wille; Simon Sharpe; Gerold Schmitt-Ulms
Journal:  Elife       Date:  2017-06-26       Impact factor: 8.140

3.  Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment.

Authors:  Haixing Wang; Wei-Jun Qian; Mark H Chin; Vladislav A Petyuk; Richard C Barry; Tao Liu; Marina A Gritsenko; Heather M Mottaz; Ronald J Moore; David G Camp Ii; Arshad H Khan; Desmond J Smith; Richard D Smith
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

4.  Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease.

Authors:  Bert C Lynn; Jianquan Wang; William R Markesbery; Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies.

Authors:  Michael T Maloney; James R Bamburg
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

6.  Quantitative proteomic analysis of mitochondria in aging PS-1 transgenic mice.

Authors:  You-Jun Fu; Shuling Xiong; Mark A Lovell; Bert C Lynn
Journal:  Cell Mol Neurobiol       Date:  2009-02-25       Impact factor: 5.046

Review 7.  Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Authors:  D Allan Butterfield; Erika M Palmieri; Alessandra Castegna
Journal:  Expert Rev Proteomics       Date:  2016       Impact factor: 3.940

8.  Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane.

Authors:  Yasuhiro Yamamoto; Kenkichi Takase; Junji Kishino; Megumi Fujita; Noboru Okamura; Toshiyuki Sakaeda; Masafumi Fujimoto; Tatsurou Yagami
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 9.  Comparative mitochondrial proteomics: perspective in human diseases.

Authors:  Yujie Jiang; Xin Wang
Journal:  J Hematol Oncol       Date:  2012-03-18       Impact factor: 17.388

10.  Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients.

Authors:  Mei Chen; Han-Kyu Lee; Lauren Moo; Eugene Hanlon; Thor Stein; Weiming Xia
Journal:  J Proteomics       Date:  2018-04-27       Impact factor: 3.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.